Evaluating Clinical Trials in COVID-19 and Pediatric Treatments

This chapter examines a recent clinical trial in Tunisia evaluating oral zinc for COVID-19, analyzing its methodology and the implications of changing primary outcomes from mortality to ICU admissions. The discussion extends to pediatric medicine, focusing on treatment practices for croup and the use of metered dose inhalers, while critiquing the reliability of published research and clinical data. The speakers highlight the importance of accurate diagnoses and cautious treatment approaches to enhance patient outcomes.